-
1
-
-
84878637915
-
Nanomedicines as cancer therapeutics: Current status
-
CCDT-EPUB-20130318-1
-
Akhter S, Ahmad I, Ahmad MZ, Ramazani F, Singh A, Rahman Z, Ahmad FJ, Storm G, Kok RJ (2013) Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets 13(4):362-378 CCDT-EPUB-20130318-1
-
(2013)
Curr Cancer Drug Targets
, vol.13
, Issue.4
, pp. 362-378
-
-
Akhter, S.1
Ahmad, I.2
Ahmad, M.Z.3
Ramazani, F.4
Singh, A.5
Rahman, Z.6
Ahmad, F.J.7
Storm, G.8
Kok, R.J.9
-
2
-
-
68949206606
-
The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide
-
doi:10.1111/j.1471-4159.2009.06228.x
-
Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 110(5):1445-1456. doi:10.1111/j.1471-4159.2009.06228.x
-
(2009)
J Neurochem
, vol.110
, Issue.5
, pp. 1445-1456
-
-
Albani, D.1
Polito, L.2
Batelli, S.3
De Mauro, S.4
Fracasso, C.5
Martelli, G.6
Colombo, L.7
Manzoni, C.8
Salmona, M.9
Caccia, S.10
Negro, A.11
Forloni, G.12
-
3
-
-
84861669644
-
Doxil® â€" The first FDA-approved nano-drug: Lessons learned
-
doi:10.1016/j.jconrel.2012.03.020
-
Barenholz Y (2012) Doxil® â€" The first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117-134. doi:10.1016/j.jconrel.2012.03.020
-
(2012)
J Control Release
, vol.160
, Issue.2
, pp. 117-134
-
-
Barenholz, Y.1
-
4
-
-
84877669643
-
Complex encounters: Nanoparticles in whole blood and their uptake into different types of white blood cells
-
doi:10.2217/nnm.12.111
-
Baumann D, Hofmann D, Nullmeier S, Panther P, Dietze C, Musyanovych A, Ritz S, Landfester K, Mailander V (2013) Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells. Nanomedicine (Lond) 8(5):699-713. doi:10.2217/nnm.12.111
-
(2013)
Nanomedicine (Lond)
, vol.8
, Issue.5
, pp. 699-713
-
-
Baumann, D.1
Hofmann, D.2
Nullmeier, S.3
Panther, P.4
Dietze, C.5
Musyanovych, A.6
Ritz, S.7
Landfester, K.8
Mailander, V.9
-
5
-
-
84893458915
-
In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools
-
doi:10.1021/nn402669w
-
Bigini P, Previdi S, Casarin E, Silvestri D, Violatto MB, Facchin S, Sitia L, Rosato A, Zuccolotto G, Realdon N, Fiordaliso F, Salmona M, Morpurgo M (2013) In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools. ACS Nano. doi:10.1021/nn402669w
-
(2013)
ACS Nano
-
-
Bigini, P.1
Previdi, S.2
Casarin, E.3
Silvestri, D.4
Violatto, M.B.5
Facchin, S.6
Sitia, L.7
Rosato, A.8
Zuccolotto, G.9
Realdon, N.10
Fiordaliso, F.11
Salmona, M.12
Morpurgo, M.13
-
6
-
-
84871700095
-
Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes
-
doi:10.3390/s121216420
-
Canovi M, Lucchetti J, Stravalaci M, Re F, Moscatelli D, Bigini P, Salmona M, Gobbi M (2013) Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. Sensors (Basel) 12(12):16420-16432. doi:10.3390/s121216420
-
(2013)
Sensors (Basel)
, vol.12
, Issue.12
, pp. 16420-16432
-
-
Canovi, M.1
Lucchetti, J.2
Stravalaci, M.3
Re, F.4
Moscatelli, D.5
Bigini, P.6
Salmona, M.7
Gobbi, M.8
-
7
-
-
84878630525
-
Nanoparticle characterization: State of the art, challenges, and emerging technologies
-
doi:10.1021/mp300697h
-
Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y (2013) Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm 10(6):2093-2110. doi:10.1021/mp300697h
-
(2013)
Mol Pharm
, vol.10
, Issue.6
, pp. 2093-2110
-
-
Cho, E.J.1
Holback, H.2
Liu, K.C.3
Abouelmagd, S.A.4
Park, J.5
Yeo, Y.6
-
8
-
-
84878314525
-
Biocompatible fluorescent nanoparticles for in vivo stem cell tracking
-
doi:10.1088/0957-4484/24/24/245603
-
Cova L, Bigini P, Diana V, Sitia L, Ferrari R, Pesce RM, Khalaf R, Bossolasco P, Ubezio P, Lupi M, Tortarolo M, Colombo L, Giardino D, Silani V, Morbidelli M, Salmona M, Moscatelli D (2013) Biocompatible fluorescent nanoparticles for in vivo stem cell tracking. Nanotechnology 24(24):245603. doi:10.1088/0957-4484/24/24/245603
-
(2013)
Nanotechnology
, vol.24
, Issue.24
, pp. 245603
-
-
Cova, L.1
Bigini, P.2
Diana, V.3
Sitia, L.4
Ferrari, R.5
Pesce, R.M.6
Khalaf, R.7
Bossolasco, P.8
Ubezio, P.9
Lupi, M.10
Tortarolo, M.11
Colombo, L.12
Giardino, D.13
Silani, V.14
Morbidelli, M.15
Salmona, M.16
Moscatelli, D.17
-
10
-
-
78751607122
-
Characteristics of triple-negative breast cancer
-
doi:10.1007/s00432-010-0957-x
-
de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137(2):183-192. doi:10.1007/s00432-010-0957-x
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, Issue.2
, pp. 183-192
-
-
De Ruijter, T.C.1
Veeck, J.2
De Hoon, J.P.3
Van Engeland, M.4
Tjan-Heijnen, V.C.5
-
11
-
-
84888865755
-
Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment
-
doi:10.1021/nn4047925
-
Deng ZJ, Morton SW, Ben-Akiva E, Dreaden EC, Shopsowitz KE, Hammond PT (2013) Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano 7(11):9571-9584. doi:10.1021/nn4047925
-
(2013)
ACS Nano
, vol.7
, Issue.11
, pp. 9571-9584
-
-
Deng, Z.J.1
Morton, S.W.2
Ben-Akiva, E.3
Dreaden, E.C.4
Shopsowitz, K.E.5
Hammond, P.T.6
-
12
-
-
84887070003
-
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
-
doi:10.1016/j.jconrel.2013.05.025
-
Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456-466. doi:10.1016/j.jconrel.2013.05.025
-
(2013)
J Control Release
, vol.172
, Issue.2
, pp. 456-466
-
-
Dobrovolskaia, M.A.1
McNeil, S.E.2
-
13
-
-
84871704201
-
Synthesis of fluorescent PMMA-based nanoparticles
-
doi:10.1002/mame.201200122
-
Dossi M, Ferrari R, Dragoni L, Martignoni C, Gaetani P, D'Incalci M, Morbidelli M, Moscatelli D (2012) Synthesis of fluorescent PMMA-based nanoparticles. Macromol Mater Eng 298(7):771-778. doi:10.1002/mame.201200122
-
(2012)
Macromol Mater Eng
, vol.298
, Issue.7
, pp. 771-778
-
-
Dossi, M.1
Ferrari, R.2
Dragoni, L.3
Martignoni, C.4
Gaetani, P.5
D'Incalci, M.6
Morbidelli, M.7
Moscatelli, D.8
-
14
-
-
84891838360
-
Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles
-
doi:10.1088/0957-4484/25/4/045102
-
Ferrari R, Lupi M, Falcetta F, Bigini P, Paolella K, Fiordaliso F, Bisighini C, Salmona M, D'Incalci M, Morbidelli M, Moscatelli D, Ubezio P (2014) Integrated multiplatform method for in vitro quantitative assessment of cellular uptake for fluorescent polymer nanoparticles. Nanotechnology 25(4):045102. doi:10.1088/0957-4484/25/4/045102
-
(2014)
Nanotechnology
, vol.25
, Issue.4
, pp. 045102
-
-
Ferrari, R.1
Lupi, M.2
Falcetta, F.3
Bigini, P.4
Paolella, K.5
Fiordaliso, F.6
Bisighini, C.7
Salmona, M.8
D'Incalci, M.9
Morbidelli, M.10
Moscatelli, D.11
Ubezio, P.12
-
15
-
-
79955383979
-
In vivo real-time multiphoton imaging of T lymphocytes in the mouse brain after experimental stroke
-
doi:10.1161/STROKEAHA.110.603704
-
Fumagalli S, Coles JA, Ejlerskov P, Ortolano F, Bushell TJ, Brewer JM, De Simoni MG, Dever G, Garside P, Maffia P, Carswell HV (2011) In vivo real-time multiphoton imaging of T lymphocytes in the mouse brain after experimental stroke. Stroke 42(5):1429-1436. doi:10.1161/STROKEAHA.110.603704
-
(2011)
Stroke
, vol.42
, Issue.5
, pp. 1429-1436
-
-
Fumagalli, S.1
Coles, J.A.2
Ejlerskov, P.3
Ortolano, F.4
Bushell, T.J.5
Brewer, J.M.6
De Simoni, M.G.7
Dever, G.8
Garside, P.9
Maffia, P.10
Carswell, H.V.11
-
16
-
-
84876486923
-
CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice
-
doi:10.1002/glia.22474
-
Fumagalli S, Perego C, Ortolano F, De Simoni MG (2013) CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61(6):827-842. doi:10.1002/glia.22474
-
(2013)
Glia
, vol.61
, Issue.6
, pp. 827-842
-
-
Fumagalli, S.1
Perego, C.2
Ortolano, F.3
De Simoni, M.G.4
-
17
-
-
84857089600
-
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer
-
doi:10.1371/journal.pone.0031070
-
Inoue S, Patil R, Portilla-Arias J, Ding H, Konda B, Espinoza A, Mongayt D, Markman JL, Elramsisy A, Phillips HW, Black KL, Holler E, Ljubimova JY (2012) Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer. PLoS One 7(2):e31070. doi:10.1371/journal.pone.0031070
-
(2012)
PLoS One
, vol.7
, Issue.2
-
-
Inoue, S.1
Patil, R.2
Portilla-Arias, J.3
Ding, H.4
Konda, B.5
Espinoza, A.6
Mongayt, D.7
Markman, J.L.8
Elramsisy, A.9
Phillips, H.W.10
Black, K.L.11
Holler, E.12
Ljubimova, J.Y.13
-
18
-
-
79951898882
-
Interactions of nanoparticles with plasma proteins: Implication on clearance and toxicity of drug delivery systems
-
doi:10.1517/17425247.2011.554818
-
Karmali PP, Simberg D (2011) Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 8(3):343-357. doi:10.1517/17425247.2011.554818
-
(2011)
Expert Opin Drug Deliv
, vol.8
, Issue.3
, pp. 343-357
-
-
Karmali, P.P.1
Simberg, D.2
-
19
-
-
84856621061
-
Expert opinion: Responsive polymer nanoparticles in cancer therapy
-
doi:10.1016/j.ejpb.2011.08.004
-
Liechty WB, Peppas NA (2012) Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm 80(2):241-246. doi:10.1016/j.ejpb.2011.08.004
-
(2012)
Eur J Pharm Biopharm
, vol.80
, Issue.2
, pp. 241-246
-
-
Liechty, W.B.1
Peppas, N.A.2
-
20
-
-
84878104912
-
Paclitaxel nano-delivery systems: A comprehensive review
-
doi:10.4172/2157-7439.1000164
-
Ma P, Mumper RJ (2013) Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol 4(2):1000164. doi:10.4172/2157-7439.1000164
-
(2013)
J Nanomed Nanotechnol
, vol.4
, Issue.2
, pp. 1000164
-
-
Ma, P.1
Mumper, R.J.2
-
21
-
-
84888419295
-
Influence of nanoparticle shape, size, and surface functionalization on cellular uptake
-
Ma N, Ma C, Li C, Wang T, Tang Y, Wang H, Moul X, Chen Z, Hel N (2013) Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J Nanosci Nanotechnol 13(10):6485-6498
-
(2013)
J Nanosci Nanotechnol
, vol.13
, Issue.10
, pp. 6485-6498
-
-
Ma, N.1
Ma, C.2
Li, C.3
Wang, T.4
Tang, Y.5
Wang, H.6
Moul, X.7
Chen, Z.8
Hel, N.9
-
22
-
-
70350292588
-
Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer
-
doi:10.1016/j.tips.2009.08.004
-
Malam Y, Loizidou M, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11):592-599. doi:10.1016/j.tips.2009.08.004
-
(2009)
Trends Pharmacol Sci
, vol.30
, Issue.11
, pp. 592-599
-
-
Malam, Y.1
Loizidou, M.2
Seifalian, A.M.3
-
23
-
-
84878170578
-
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
-
doi:10.2147/IJN.S43683
-
Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash S (2013) Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. Int J Nanomed 8:2041-2052. doi:10.2147/IJN. S43683
-
(2013)
Int J Nanomed
, vol.8
, pp. 2041-2052
-
-
Malhotra, M.1
Tomaro-Duchesneau, C.2
Saha, S.3
Kahouli, I.4
Prakash, S.5
-
24
-
-
57249084773
-
Polymeric micellar delivery systems in oncology
-
doi:10.1093/jjco/hyn116
-
Matsumura Y (2008) Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol 38(12):793-802. doi:10.1093/jjco/hyn116
-
(2008)
Jpn J Clin Oncol
, vol.38
, Issue.12
, pp. 793-802
-
-
Matsumura, Y.1
-
25
-
-
84873853768
-
Biomolecular coronas provide the biological identity of nanosized materials
-
doi:10.1038/nnano.2012.207
-
Monopoli MP, Aberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7(12):779-786. doi:10.1038/nnano.2012.207
-
(2012)
Nat Nanotechnol
, vol.7
, Issue.12
, pp. 779-786
-
-
Monopoli, M.P.1
Aberg, C.2
Salvati, A.3
Dawson, K.A.4
-
26
-
-
84865264928
-
Combinatorial nanoparticles for cancer diagnosis and therapy
-
CMC-EPUB-20120607-22 [pii]
-
Mukerjee A, Ranjan AP, Vishwanatha JK (2012) Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem 19(22):3714-3721 CMC-EPUB-20120607-22 [pii]
-
(2012)
Curr Med Chem
, vol.19
, Issue.22
, pp. 3714-3721
-
-
Mukerjee, A.1
Ranjan, A.P.2
Vishwanatha, J.K.3
-
27
-
-
84890996933
-
Nanomaterials in combating cancer: Therapeutic applications and developments
-
doi:10.1016/j.nano.2013.07.001
-
Nazir S, Hussain T, Ayub A, Rashid U, Macrobert AJ (2014) Nanomaterials in combating cancer: therapeutic applications and developments. Nanomedicine 10(1):19-34. doi:10.1016/j.nano.2013.07.001
-
(2014)
Nanomedicine
, vol.10
, Issue.1
, pp. 19-34
-
-
Nazir, S.1
Hussain, T.2
Ayub, A.3
Rashid, U.4
Macrobert, A.J.5
-
28
-
-
79151476662
-
Triple negative breast cancer: Unmet medical needs
-
doi:10.1007/s10549-010-1293-1
-
Pal SK, Childs BH, Pegram M (2011) Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125(3):627-636. doi:10.1007/s10549-010- 1293-1
-
(2011)
Breast Cancer Res Treat
, vol.125
, Issue.3
, pp. 627-636
-
-
Pal, S.K.1
Childs, B.H.2
Pegram, M.3
-
29
-
-
84855824016
-
Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging
-
doi:10.1016/j.nano.2011.05.016
-
Parveen S, Misra R, Sahoo SK (2011) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8(2):147-166. doi:10.1016/j.nano.2011.05.016
-
(2011)
Nanomedicine
, vol.8
, Issue.2
, pp. 147-166
-
-
Parveen, S.1
Misra, R.2
Sahoo, S.K.3
-
30
-
-
36849067019
-
Nanocarriers as an emerging platform for cancer therapy
-
DOI 10.1038/nnano.2007.387, PII NNANO2007387
-
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751-760. doi:10.1038/nnano.2007.387 (Pubitemid 350223348)
-
(2007)
Nature Nanotechnology
, vol.2
, Issue.12
, pp. 751-760
-
-
Peer, D.1
Karp, J.M.2
Hong, S.3
Farokhzad, O.C.4
Margalit, R.5
Langer, R.6
-
31
-
-
77955175216
-
Strategies in the design of nanoparticles for therapeutic applications
-
doi:10.1038/nrd2591
-
Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615-627. doi:10.1038/nrd2591
-
(2010)
Nat Rev Drug Discov
, vol.9
, Issue.8
, pp. 615-627
-
-
Petros, R.A.1
DeSimone, J.M.2
-
32
-
-
33244478081
-
Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion
-
doi:10.1371/journal.pbio.0040022
-
Schaffer CB, Friedman B, Nishimura N, Schroeder LF, Tsai PS, Ebner FF, Lyden PD, Kleinfeld D (2006) Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion. PLoS Biol 4(2):e22. doi:10.1371/journal.pbio.0040022
-
(2006)
PLoS Biol
, vol.4
, Issue.2
-
-
Schaffer, C.B.1
Friedman, B.2
Nishimura, N.3
Schroeder, L.F.4
Tsai, P.S.5
Ebner, F.F.6
Lyden, P.D.7
Kleinfeld, D.8
-
33
-
-
84855961163
-
Nanoparticle delivery of cancer drugs
-
doi:10.1146/annurev-med-040210-162544
-
Wang AZ, Langer R, Farokhzad OC (2011) Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185-198. doi:10.1146/annurev-med-040210-162544
-
(2011)
Annu Rev Med
, vol.63
, pp. 185-198
-
-
Wang, A.Z.1
Langer, R.2
Farokhzad, O.C.3
-
34
-
-
84890834106
-
Nanomedicine: De novo design of nanodrugs
-
doi:10.1039/c3nr04535h
-
Yang Z, Kang SG, Zhou R (2013) Nanomedicine: de novo design of nanodrugs. Nanoscale 6(2):663-677. doi:10.1039/c3nr04535h
-
(2013)
Nanoscale
, vol.6
, Issue.2
, pp. 663-677
-
-
Yang, Z.1
Kang, S.G.2
Zhou, R.3
|